首页> 美国卫生研究院文献>Journal of Virology >Kaposis Sarcoma-Associated Herpesvirus-Encoded Viral IRF3 Modulates Major Histocompatibility Complex Class II (MHC-II) Antigen Presentation through MHC-II Transactivator-Dependent and -Independent Mechanisms: Implications for Oncogenesis
【2h】

Kaposis Sarcoma-Associated Herpesvirus-Encoded Viral IRF3 Modulates Major Histocompatibility Complex Class II (MHC-II) Antigen Presentation through MHC-II Transactivator-Dependent and -Independent Mechanisms: Implications for Oncogenesis

机译:卡波济氏肉瘤相关疱疹病毒编码的病毒IRF3调节主要组织相容性复杂II类(MHC-II)抗原通过MHC-II反式激活子和非依赖性机制呈递:对肿瘤发生的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Evasion of immune T cell responses is crucial for persistent viruses to establish a normal carrier state. Most studies on active immune modulation mechanisms have focused on the stage of virus production in infected cells, when large numbers of viral antigens and potential immune modulators are expressed. For oncogenic viruses such as Kaposi's sarcoma-associated herpesvirus (KSHV), which is carried as a lifelong infection, usually with little harmful effect, but can cause various tumors, the immune evasion strategies can also be relevant in the context of tumorigenesis. Here we report that the virus-encoded interferon regulatory factor 3 (vIRF3) latent viral gene expressed in KSHV-related tumors functions as a potent immunevasin. Expression of vIRF3 downregulates surface major histocompatibility complex class II (MHC-II) DR expression with slow kinetics but, more importantly, can substantially inhibit recognition by KSHV-specific CD4 T cells prior to its effects on MHC-II DR downregulation in model cell systems. This property of vIRF3 is only partly due to its ability to inhibit the transcription of CIITA and, thus, MHC-II expression; CIITA-independent inhibition of MHC-II transcripts and another as yet unidentified posttranscriptional mechanism are also involved in qualitatively modulating the availability of specific peptide/MHC-II complexes at the cell surface. Consistent with these observations, the vIRF3-expressing KSHV-associated primary effusion lymphoma (PEL) lines are generally resistant to recognition by KSHV-specific CD4 T cells. Interestingly, some PEL lines exhibit small subpopulations with lower vIRF3 expression that can be recognized. These data implicate vIRF3 as a critical determinant of the MHC-II antigen presentation function in KSHV-associated PELs that is likely to be important in the pathogenesis of these tumors.
机译:逃避免疫T细胞反应对于持久性病毒建立正常载体状态至关重要。关于主动免疫调节机制的大多数研究都集中在表达大量病毒抗原和潜在免疫调节剂时感染细胞中病毒产生的阶段。对于致癌病毒,例如卡波西氏肉瘤相关疱疹病毒(KSHV),这种病毒通常是一生的感染,通常几乎没有有害作用,但是可以引起多种肿瘤,因此免疫逃逸策略也可能与肿瘤发生有关。在这里我们报告说,在KSHV相关肿瘤中表达的病毒编码干扰素调节因子3(vIRF3)潜伏病毒基因起着有效的免疫血管生成作用。 vIRF3的表达以缓慢的动力学下调了表面主要组织相容性复合物II类(MHC-II)DR的表达,但更重要的是,在其对模型细胞系统中MHC-II DR的下调产生影响之前,可以显着抑制KSHV特异性CD4 T细胞的识别。 。 vIRF3的这种特性仅部分是由于其抑制CIITA转录的能力,以及抑制MHC-II表达的能力。不依赖CIITA抑制MHC-II转录本以及另一种尚未确定的转录后机制也涉及定性调节细胞表面特定肽/ MHC-II复合物的可用性。与这些观察结果一致,表达vIRF3的KSHV相关原发性淋巴瘤(PEL)株通常对KSHV特异性CD4 T细胞的识别具有抗性。有趣的是,一些PEL品系表现出较小的亚群,具有可以识别的较低vIRF3表达。这些数据表明,vIRF3是与KSHV相关的PEL中MHC-II抗原呈递功能的关键决定因素,而这在这些肿瘤的发病机理中可能很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号